In prostate cancer, ABCC5‐bound CDK1 has been found to directly phosphorylate the AR transcription factor to stimulate its activity, further highlighting that CDK1 might possess non‐mitotic transcriptional roles in different cellular contexts (Ji et al., 2021). Here, CDK1 is linked to prostate carcinoma.